US › Healthcare

eXoZymes, Inc. (EXOZ)

US · Healthcare · Biotechnology

$4.62+0.43%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-2.4M
Profit YoY
-27.7%
EPS
$-0.28

Key statistics

Market cap
$42.7M
Forward P/E
0.0
P/B
28.24
Book value
$0.18
EPS (TTM)
$-1.15
52-week high
$18.40
52-week low
$4.35
50-day MA
$7.45
200-day MA
$10.20

Shareholding

Insiders
64.53%
Institutions
0.95%

Largest institutional holders

FundStake
Davidson Kahn Capital Management, LLC0.27%
Vanguard Capital Management, LLC0.24%
Geode Capital Management, LLC0.24%
Vanguard Fiduciary Trust Co0.10%
BlackRock Inc0.07%
Tower Research Capital LLC0.01%
Morgan Stanley - Brokerage Accounts0.01%
UBS Group AG0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for eXoZymes, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.